Menopause and your heart: the disease that kills the most women (and no one talks about)

14 min · Published July 27, 2026 · 13 PubMed studies cited · menopause · heart · cardiovascular

Cardiovascular disease is the leading cause of death in women, and yet it is almost never discussed at the time of menopause. What the transition really changes in your lipid profile and your body composition, the risk signals specific to women (frequent hot flashes, early menopause, persistent insomnia), why your pregnancy history is part of your cardiology file, how to recognize a heart attack in a woman, and what the WHI and ELITE really say about hormone therapy and the heart. In French with English subtitles.

Watch on YouTube (full description and references) →

Read the written and sourced version of this topic →

What you will understand

Cardiovascular disease is the leading cause of death in women. The American Heart Association writes it in black and white in its 2020 scientific statement, and yet, at the time of menopause, the talk is about breast cancer or osteoporosis, almost never about the heart. This silence has a history: for decades, heart attacks were treated as the problem of stressed men in a hurry. Women were less included in trials, less screened, less treated.

This video repairs that silence, without alarmism. Menopause is not a disease and it does not cause heart attacks. It is a transition period during which several risk factors evolve at the same time and without noise: the lipid profile becomes more atherogenic, body composition changes (the rate of fat mass gain doubles, lean mass declines), and certain signals specific to women appear. The AHA speaks of a "critical window for early prevention": in other words, an opportunity, not a sentence.

It also dismantles a widespread and dangerous myth: the one according to which women do not have chest pain during a heart attack. The VIRGO study, conducted among 2,009 women and 976 men hospitalized in more than one hundred hospitals, shows that 87% of women did present chest pain. The real difference is not in women's bodies, it is in the interpretation of their symptoms, by themselves and by caregivers. Finally, the question of hormone therapy is treated without complacency: the figures from the WHI and ELITE are given as they are.

The key points to remember

  • Cardiovascular disease is the #1 cause of death in women (AHA, PMID 33251828).
  • What changes at menopause: the lipid profile and body composition, not necessarily the number on the scale.
  • Frequent, persistent hot flashes, early menopause or chronic insomnia are signals associated with a higher risk. An observed association, not a cause-and-effect relationship.
  • Preeclampsia, gestational diabetes or a very premature delivery are part of your cardiology file: your doctor needs to know, even twenty years later.
  • 87% of women have chest pain during a heart attack. Faced with pain in the chest, call emergency services.
  • Menopause hormone therapy is NOT indicated for cardiovascular prevention (WHI, cardiovascular mortality HR 1.00 over 18 years).

Video chapters

  1. 0:00 Women's hearts, medicine's blind spot
  2. 1:47 What menopause really changes
  3. 3:40 Hot flashes, early menopause, insomnia: the female signals
  4. 5:59 Your pregnancies are part of your cardiology file
  5. 7:54 Recognizing a heart attack in a woman
  6. 9:40 MHT and the heart: what the WHI and ELITE really say
  7. 11:38 What really protects + recap

The scientific sources cited

Every claim in this video rests on a verified reference. Here is the complete list, with the PubMed links. You will find these studies detailed in the written and sourced version of this topic.

  • El Khoudary SR, et al. Menopause Transition and Cardiovascular Disease Risk. AHA Scientific Statement. Circulation 2020. PubMed 33251828
  • El Khoudary SR, et al. Anti-Müllerian hormone, estradiol and lipids across the menopause transition (SWAN). J Clin Lipidol 2023. PubMed 36517413
  • Greendale GA, et al. Changes in body composition and weight during the menopause transition. JCI Insight 2019. PubMed 30843880
  • Thurston RC, et al. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. JAHA 2021. PubMed 33470142
  • Zhu D, et al. Age at natural menopause and risk of incident cardiovascular disease: pooled analysis. Lancet Public Health 2019. PubMed 31588031
  • Thurston RC, et al. Trajectories of Sleep Over Midlife and Incident Cardiovascular Disease Events (SWAN). Circulation 2024. PubMed 38284249
  • Parikh NI, et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk. AHA Scientific Statement. Circulation 2021. PubMed 33779213
  • Xie W, et al. Gestational diabetes mellitus and cardiovascular and cerebrovascular diseases: meta-analysis. BMJ 2022. PubMed 36130740
  • Lichtman JH, et al. Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction (VIRGO). Circulation 2018. PubMed 29459463
  • Manson JE, et al. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality (WHI). JAMA 2017. PubMed 28898378
  • Hodis HN, et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE). NEJM 2016. PubMed 27028912
  • Ji H, et al. Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality. JACC 2024. PubMed 38383092
  • Pant A, et al. Primary prevention of cardiovascular disease in women with a Mediterranean diet: meta-analysis. Heart 2023. PubMed 36918266

Frequently asked questions

Does menopause hormone therapy protect the heart?

No. The 18-year follow-up of the Women's Health Initiative, covering 27,347 randomized women, gives a hazard ratio of 1.00 for cardiovascular mortality: a strictly neutral result. MHT is neither indicated nor recommended for cardiovascular prevention. The ELITE trial showed a slowing of carotid wall thickening in women treated shortly after menopause, but no effect on coronary calcium, stenosis or plaque: an imaging marker is not a heart attack avoided.

Do hot flashes damage the arteries?

No. In the SWAN cohort, women with frequent hot flashes later had a risk of cardiovascular events increased by about 51%, and 77% if those flashes persisted. But it is an observed association, not a cause-and-effect relationship, and nothing indicates that treating them reduces cardiovascular risk. They can, however, be a signal that deserves a check-up.

Is it true that women have "atypical" heart attack symptoms?

It is largely a myth, and a dangerous one. In the VIRGO study, 87% of women hospitalized for a heart attack had chest pain, versus 89.5% of men. Women more often presented three or more associated symptoms and more often attributed their symptoms to stress. Above all, 53% of those who had consulted before hospitalization reported that the caregiver had not thought it was cardiac, versus 37% of men.

What should I do about a history of preeclampsia or gestational diabetes?

Talk to your doctor about it. The American Heart Association recognizes that pregnancy complications increase later cardiovascular risk, while specifying that their value for recalculating risk is not established. So it is not a score, it is a clinical warning signal that justifies more attentive prevention: monitored blood pressure, lipid panel, blood sugar.

What does menopause really change for the heart?

It modifies several risk factors at the same time, and without noise. The lipid profile becomes more atherogenic, body composition transforms, with a rate of fat mass gain that doubles and lean mass that declines. The number on the scale can therefore stay stable while the risk evolves. The American Heart Association speaks in this regard of a critical window for early prevention, that is, an opportunity rather than a sentence.

Does early menopause change cardiovascular risk?

It is a signal to know about. A pooled analysis published in Lancet Public Health associated an earlier age at natural menopause with a higher risk of later cardiovascular events. This predicts nothing at the individual level, but it justifies having this information in the file and making prevention, blood pressure, lipid panel, blood sugar, a little more attentive.

Does sleep matter for women's hearts?

Cohort data suggest it does. An analysis of sleep trajectories through the forties and fifties, conducted in the SWAN study, was associated with the later occurrence of cardiovascular events. Chronic insomnia is therefore not only a question of comfort: it is something to mention in consultation, in the same way as frequent hot flashes or early menopause.

What really protects, in practice?

The documented levers are not spectacular, but they are real. An analysis published in JACC examined the association between physical activity and cardiovascular mortality in women and in men, and a meta-analysis published in Heart evaluated the Mediterranean-style diet in primary prevention in women. Added to these are monitoring of blood pressure, lipid panel and blood sugar, and quitting smoking.